Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomized, Parallel-Group, Multi-Site Study to Evaluate the Efficacy and Safety of Azelastine HCl-Fluticasone Propionate Nasal Spray 137-50 mcg/Spray in Perennial Allergic Rhinitis Patients

NCT06051786 is registered in ClinicalTrials.gov with Synmosa Biopharma Corp. as lead sponsor.

NCT NCT06051786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomized, Parallel-Group, Multi-Site Study to Evaluate the Efficacy and Safety of Azelastine HCl-Fluticasone Propionate Nasal Spray 137-50 mcg/Spray in Perennial Allergic Rhinitis Patients
Lead sponsor
Synmosa Biopharma Corp.
Phase
Phase 2
Overall status
Completed
Start date
August 20, 2020
Completion date
July 20, 2021
Enrollment
136 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis